Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.85 - $10.93 $114,345 - $324,621
29,700 New
29,700 $270,000
Q3 2023

Nov 14, 2023

BUY
$3.14 - $5.04 $314,963 - $505,547
100,307 Added 402.95%
125,200 $393,000
Q2 2023

Aug 11, 2023

SELL
$4.6 - $7.64 $212,979 - $353,732
-46,300 Reduced 65.03%
24,893 $128,000
Q1 2023

May 12, 2023

SELL
$2.79 - $6.27 $621,612 - $1.4 Million
-222,800 Reduced 75.78%
71,193 $375,000
Q4 2022

Feb 13, 2023

BUY
$2.61 - $4.41 $728,712 - $1.23 Million
279,200 Added 1887.38%
293,993 $826,000
Q3 2022

Nov 14, 2022

SELL
$4.09 - $6.5 $1.5 Million - $2.38 Million
-366,707 Reduced 96.12%
14,793 $61,000
Q2 2022

Aug 12, 2022

SELL
$3.01 - $5.22 $389,208 - $674,972
-129,305 Reduced 25.31%
381,500 $1.53 Million
Q1 2022

May 13, 2022

BUY
$4.83 - $7.35 $2.08 Million - $3.17 Million
430,705 Added 537.71%
510,805 $2.53 Million
Q4 2021

Feb 11, 2022

SELL
$6.16 - $12.07 $1.02 Million - $2 Million
-166,100 Reduced 67.47%
80,100 $558,000
Q3 2021

Nov 12, 2021

SELL
$9.7 - $14.34 $784,943 - $1.16 Million
-80,922 Reduced 24.74%
246,200 $2.46 Million
Q2 2021

Aug 13, 2021

BUY
$13.43 - $19.16 $3.72 Million - $5.31 Million
277,222 Added 555.56%
327,122 $4.64 Million
Q1 2021

May 13, 2021

SELL
$15.82 - $22.11 $4.5 Million - $6.28 Million
-284,166 Reduced 85.06%
49,900 $819,000
Q4 2020

Feb 10, 2021

BUY
$7.91 - $22.95 $2.64 Million - $7.67 Million
334,066 New
334,066 $6.92 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.